Barbara J Nicklas Selected Research

Caloric Restriction

10/2022	Predictors of Clinically Meaningful Gait Speed Response to Caloric Restriction Among Older Adults Participating in Weight Loss Interventions.
1/2022	Evaluation of a blood-based geroscience biomarker index in a randomized trial of caloric restriction and exercise in older adults with heart failure with preserved ejection fraction.
1/2022	Estimating heterogeneity of physical function treatment response to caloric restriction among older adults with obesity.
1/2021	Effects of Exercise and Weight Loss on Proximal Aortic Stiffness in Older Adults With Obesity.
1/2019	Cognitive Effects of Adding Caloric Restriction to Aerobic Exercise Training in Older Adults with Obesity.
1/2019	Effects of Caloric Restriction on Cardiorespiratory Fitness, Fatigue, and Disability Responses to Aerobic Exercise in Older Adults With Obesity: A Randomized Controlled Trial.
10/2017	Change in Bone Mineral Density During Weight Loss with Resistance Versus Aerobic Exercise Training in Older Adults.
1/2017	Effect of Resistance Training and Caloric Restriction on the Metabolic Syndrome.
4/2016	Effects of Resistance Training With and Without Caloric Restriction on Arterial Stiffness in Overweight and Obese Older Adults.
1/2016	Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara J Nicklas Research Topics

Disease

36	Weight Loss (Weight Reduction) 10/2022 - 02/2003
19	Overweight 10/2022 - 01/2002
18	Inflammation (Inflammations) 01/2017 - 11/2003
17	Obesity 01/2022 - 08/2003
10	Insulin Resistance 01/2017 - 01/2002
9	Body Weight (Weight, Body) 01/2017 - 01/2002
8	Pain (Aches) 07/2021 - 04/2008
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 04/2005
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 09/2003
4	Heart Failure 01/2022 - 09/2003
4	Abdominal Obesity 04/2005 - 01/2002
3	Hypertension (High Blood Pressure) 10/2022 - 10/2004
3	Fatigue 01/2019 - 04/2016
3	Chronic Disease (Chronic Diseases) 01/2017 - 04/2005
3	Stroke (Strokes) 12/2006 - 09/2003
2	Knee Osteoarthritis 01/2021 - 10/2005
2	Type 2 Diabetes Mellitus (MODY) 10/2015 - 08/2003
2	Disease Progression 07/2013 - 07/2009
2	Atherosclerosis 05/2009 - 06/2006
2	Necrosis 05/2009 - 04/2005
2	Mobility Limitation (Difficulty Walking) 10/2005 - 07/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Chronic Pain 05/2018
1	Colorectal Neoplasms (Colorectal Cancer) 04/2016
1	Arthritis (Polyarthritis) 07/2013
1	Vitamin D Deficiency 04/2011
1	Diabetes Mellitus 11/2008
1	Osteoarthritis 04/2008
1	Sarcopenia 01/2008
1	Myocardial Infarction 12/2006
1	Hyperinsulinism (Hyperinsulinemia) 06/2006
1	Dyslipidemias (Dyslipidemia) 01/2004
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2003
1	Peripheral Arterial Disease 09/2003
1	Coronary Disease (Coronary Heart Disease) 02/2003

Drug/Important Bio-Agent (IBA)

19	Interleukin-6 (Interleukin 6)IBA 10/2022 - 09/2003
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2004
12	CytokinesIBA 01/2017 - 09/2003
10	C-Reactive ProteinIBA 10/2022 - 09/2003
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2012 - 09/2003
9	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2002
9	Insulin (Novolin)FDA Link 01/2015 - 01/2002
6	AdiponectinIBA 11/2015 - 08/2003
6	AdipokinesIBA 09/2011 - 06/2006
4	LipidsIBA 01/2017 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2008
4	InterleukinsIBA 07/2013 - 09/2003
4	oxidized low density lipoproteinIBA 05/2009 - 01/2002
4	Lipoproteins (Lipoprotein)IBA 10/2005 - 01/2002
3	CholesterolIBA 10/2015 - 01/2002
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2013 - 09/2003
3	LeptinIBA 07/2013 - 08/2003
3	Plasminogen Activator Inhibitor 1IBA 05/2009 - 12/2006
2	N 30IBA 07/2021 - 05/2018
2	Pioglitazone (Actos)FDA Link 07/2013 - 08/2011
2	LDL CholesterolIBA 06/2013 - 07/2002
2	Triglycerides (Triacylglycerol)IBA 06/2013 - 01/2009
2	HDL CholesterolIBA 01/2009 - 10/2004
2	Dietary ProteinsIBA 07/2008 - 01/2008
2	Nonesterified Fatty Acids (NEFA)IBA 06/2006 - 06/2006
2	Indicators and Reagents (Reagents)IBA 06/2004 - 11/2003
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	SolutionsIBA 01/2021
1	GhrelinIBA 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2015
1	Phosphorus (Red Phosphorus)IBA 10/2015
1	Hormones (Hormone)IBA 07/2014
1	HDL LipoproteinsIBA 06/2013
1	LipopolysaccharidesIBA 11/2012
1	Lipopolysaccharide ReceptorsIBA 11/2012
1	lipopolysaccharide-binding proteinIBA 11/2012
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2012
1	A-factor (Streptomyces)IBA 10/2012
1	SodiumIBA 09/2011
1	25-hydroxyvitamin DIBA 04/2011
1	hydroxide ionIBA 04/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2010
1	Tumor Biomarkers (Tumor Markers)IBA 05/2009
1	Antihypertensive Agents (Antihypertensives)IBA 01/2009
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2009
1	Plasminogen InactivatorsIBA 12/2006
1	Messenger RNA (mRNA)IBA 06/2006
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2006
1	Rosiglitazone (Avandia)FDA Link 06/2006
1	Type II Tumor Necrosis Factor ReceptorsIBA 10/2005
1	Actins (F Actin)IBA 04/2005
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2004
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2004
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2003
1	Cytokine Receptors (Cytokine Receptor)IBA 09/2003
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 09/2003

Therapy/Procedure

17	Caloric Restriction 10/2022 - 07/2008
12	Resistance Training 01/2021 - 08/2011
5	Therapeutics 01/2020 - 02/2003
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 09/2011 - 09/2009
1	Drug Therapy (Chemotherapy) 04/2016
1	Bariatric Surgery 09/2011
1	Operative Surgical Procedures 09/2009
1	Lipectomy (Liposuction) 02/2006